Veronica Gibaja
4PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 05, 2024
Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in Cancer.Robinson Triboulet, Khikmet Sadykov, Darren M Harvey
|Aug 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner.Lily L Nguyen, Zachary L Watson, Raquel Ortega
|Jun 12, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.Lily L Nguyen, Zachary L Watson, Raquel Ortega
|May 07, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.Lily L Nguyen, Zachary L Watson, Raquel Ortega
Pageof 1
Frequent Collaborators
3 joint publications
Lily L Nguyen
3 joint publications
Zachary L Watson
3 joint publications
Raquel Ortega
3 joint publications
Elizabeth R Woodruff
3 joint publications
Kimberly R Jordan
3 joint publications
Ritsuko Iwanaga
3 joint publications
Tomomi M Yamamoto
3 joint publications
Courtney A Bailey
3 joint publications
Francis To
3 joint publications
Abigail D Jeong
